These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9642933)
1. [Prognostic value of myocardial 123I-BMIPP imaging in patients with congestive heart failure without coronary artery disease]. Narita M; Kurihara T; Sindoh T; Sawada Y; Honda M Kaku Igaku; 1998 Apr; 35(4):229-37. PubMed ID: 9642933 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?]. Narita M; Kurihara T J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388 [TBL] [Abstract][Full Text] [Related]
3. [Successive myocardial fatty acid metabolic imaging in patients with dilated cardiomyopathy: usefulness as a prognostic indicator]. Narita M; Kurihara T; Sindoh T; Sawada Y; Honda M Kaku Igaku; 2000 Jul; 37(4):303-10. PubMed ID: 10965650 [TBL] [Abstract][Full Text] [Related]
4. [Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: characteristics and prognostic implications]. Narita M; Kurihara T J Cardiol; 1995 May; 25(5):223-31. PubMed ID: 7776191 [TBL] [Abstract][Full Text] [Related]
6. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231 [TBL] [Abstract][Full Text] [Related]
7. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?]. Narita M; Kurihara T; Usami M; Honda M Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646 [TBL] [Abstract][Full Text] [Related]
8. Prediction of cardiac events in patients with dilated cardiomyopathy using 123I-BMIPP and 201Tl myocardial scintigraphy. Inoue A; Fujimoto S; Yamashina S; Yamazaki J Ann Nucl Med; 2007 Sep; 21(7):399-404. PubMed ID: 17876553 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging. Matsuki T; Tamaki N; Nakata T; Doi A; Takahashi H; Iwata M; Sakamoto T; Yamauchi K; Shimazaki M; Morita K; Shimamoto K Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1585-91. PubMed ID: 15583913 [TBL] [Abstract][Full Text] [Related]
10. [Usefulness of 123I-BMIPP myocardial scintigraphy for evaluation of the left ventricular function in patients with chronic heart failure]. Watanabe K; Sekiya M; Tsuruoka T; Funada J; Miyagawa M; Kumano S Kaku Igaku; 1996 Jul; 33(7):743-51. PubMed ID: 8803443 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure. Seto H; Shimizu M; Nozawa T; Yoshida N; Inagaki S; Kageyama M; Kakishita M Nucl Med Commun; 1996 Mar; 17(3):225-30. PubMed ID: 8692490 [TBL] [Abstract][Full Text] [Related]
12. 123I-BMIPP delayed scintigraphic imaging in patients with chronic heart failure. Kida K; Akashi YJ; Yoneyama K; Shimokawa M; Musha H Ann Nucl Med; 2008 Nov; 22(9):769-75. PubMed ID: 19039555 [TBL] [Abstract][Full Text] [Related]
13. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. Taki J; Nakajima K; Matsunari I; Bunko H; Takata S; Kawasuji M; Tonami N J Nucl Med; 1997 Oct; 38(10):1503-10. PubMed ID: 9379183 [TBL] [Abstract][Full Text] [Related]
14. The significance of 123I-BMIPP delayed scintigraphic imaging in cardiac patients. Akashi YJ; Kida K; Suzuki K; Inoue K; Kawasaki K; Yamauchi M; Musha H; Anker SD Int J Cardiol; 2007 Apr; 117(2):145-51. PubMed ID: 16843549 [TBL] [Abstract][Full Text] [Related]
17. Iodine-123 BMIPP scintigraphy in the evaluation of patients with heart failure. Nakae I; Matsuo S; Koh T; Mitsunami K; Horie M Acta Radiol; 2006 Oct; 47(8):810-6. PubMed ID: 17050361 [TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy]. Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884 [TBL] [Abstract][Full Text] [Related]
19. [Phase 3 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism--a multi-center trial]. Torizuka K; Yonekura Y; Nishimura T; Ohtake T; Bunko H; Tamaki N; Uehara T Kaku Igaku; 1992 Apr; 29(4):413-33. PubMed ID: 1602637 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of (123)I-BMIPP with myocardial imaging for evaluation of the efficacy of drug therapy in patients with chronic heart failure. Watanabe K; Sekiya M; Tsuruoka T; Funada JI; Miyagawa M J Card Fail; 2001 Sep; 7(3):257-64. PubMed ID: 11561227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]